Clinical Trial: Effect of Maridebart Cafraglutide on the Heart's Electrical Activity

U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07229157) titled 'Effect of Maridebart Cafraglutide on the Heart's Electrical Activity' on Nov. 13.

Brief Summary: The main objective of this trial is to evaluate the effect of maridebart cafraglutide subcutaneously (SC) on the placebo-corrected, change from baseline in QT interval corrected for heart rate using Fridericia's formula in participants living with overweight or obesity.

Study Start Date: Nov. 18

Study Type: INTERVENTIONAL

Condition: Overweight Obesity

Intervention: DRUG: Maridebart Cafraglutide

Participants will receive maridebart cafraglutide SC.

DRUG: Moxifloxacin

Participants will receive moxifloxacin orally.

DRUG: Placebo f...